Caredx Inc buy melinda
Start price
26.04.16
/
50%
€4.11
Target price
09.06.16
€4.69
Performance (%)
15.13%
End price
09.06.16
€4.74
Summary
This prediction ended on 09.06.16 with a price of €4.74. The prediction had a final performance of 15.13%. melinda has 50% into this predictionCareDx is a publicly traded biotechnology company that specializes in providing innovative transplant solutions for patients suffering from various diseases. The company has developed a range of diagnostic solutions that help doctors monitor the health of organ transplant recipients, including tests that can detect early signs of organ rejection. CareDx has a strong track record of developing cutting-edge medical technologies and working with leading healthcare providers to improve patient outcomes. As a publicly-listed company, CareDx has a diverse shareholder base and is subject to the scrutiny of regulatory bodies, providing transparency and accountability to investors.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Caredx Inc | 3.213% | 3.213% | -15.256% | 58.964% |
| iShares Core DAX® | 1.732% | 4.638% | 21.634% | 71.886% |
| iShares Nasdaq 100 | 3.304% | 0.517% | 5.422% | 113.046% |
| iShares Nikkei 225® | 2.342% | 0.972% | 15.333% | 47.267% |
| iShares S&P 500 | 2.357% | 0.872% | 3.125% | 68.687% |